<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6661876\results\search\drugs\results.xml">
  <result pre="progeny from the cell surface. Three FDA-approved NAIs are oseltamivir," exact="peramivir" post="and zanamivir.[16] Wang et al.[17] performed a multicenter, retrospective"/>
  <result pre="NAI combination treatment and monotherapy or between standard-dose and double-dose" exact="oseltamivir" post="treatment. Another antiviral drug is the adamantanes inhibitors, including"/>
  <result pre="treatment. Another antiviral drug is the adamantanes inhibitors, including adamantanes," exact="rimantadine" post="and amantadine. They target the M2 ion channel of"/>
  <result pre="most dynamic mutations. The NA R292K mutation is associated with" exact="oseltamivir" post="resistance. Due to the constant variability of the virus"/>
  <result pre="et al.[27] found that high-dose corticosteroid therapy (&amp;gt; 150 mg/d" exact="methylprednisolone" post="or equivalent) significantly increased both 30-day and 60-day mortality,"/>
  <result pre="impact was observed for low-to-moderate doses of corticosteroids (25â€“150 mg/d" exact="methylprednisolone" post="or equivalent). Li et al.[28] found that patients with"/>
 </snippets>
</snippetsTree>
